Wednesday, February 13, 2008
BLOGSCAN - More on Manipulation of Paxil Data
On the Clinical Psychology and Psychiatry blog, this post dissected allegations that GlaxoSmithKline manipulated data about suicidal ideation as an adverse effect of the drug Paxil (paroxetine , Seroxat in the UK ). (See our related post here.) The post concentrated on how key opinion leaders allayed fears about these advere effects based on summaries of data that had been processed by the company, data the company may have manipulated. Meanwhile, on the Scientific Misconduct Blog, Dr Aubrey Blumsohn noted how the current CEO of GSK chastised journalists for reporting on scientific data (unfavorable to the company) before scientists had looked at it, which makes more sense if the scientists to whom he was alluding were the sorts who are inclined to accept company processed data as is.